Taizo Hirata
Overview
Explore the profile of Taizo Hirata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masuda T, Hirata T, Sakamoto T, Tsubata Y, Ichihara E, Kozuki T, et al.
J Thorac Dis
. 2024 Jun;
16(5):3381-3388.
PMID: 38883673
Background: There is no established standard 3 line treatment for patients with advanced non-small cell lung cancer (NSCLC). Although cytotoxic chemotherapeutic agents that are not used as 1 or 2...
2.
Oshita K, Kuroda S, Kobayashi T, Aoki G, Mashima H, Onoe T, et al.
Cureus
. 2023 Dec;
15(11):e49028.
PMID: 38116351
Purpose: This study evaluated the safety and feasibility of a technique of liver resection named dual-wield parenchymal transection technique (DWT), using cavitron ultrasonic surgical aspirator (CUSA) and water-jet scalpel simultaneously....
3.
Ide K, Nakano R, Imaoka Y, Sakai H, Ono K, Tanimine N, et al.
Transplant Direct
. 2023 Feb;
9(3):e1454.
PMID: 36845857
Methods: A living-donor nephrectomy was performed using a minimum skin incision procedure. After back table preparation, the kidney graft was placed inside the TBB and preserved during vascular anastomosis. The...
4.
Ohira M, Kobayashi T, Tanaka Y, Imaoka Y, Sato K, Imaoka K, et al.
BMJ Open
. 2022 Nov;
12(11):e064526.
PMID: 36410831
Introduction: Hepatocellular carcinoma (HCC) remains a major clinical problem as more than half of these cases recur after radical resection. Natural killer (NK) cells are at the forefront of the...
5.
Hayashino K, Zaitsu J, Kuraoka K, Hirata T
Intern Med
. 2022 Jul;
62(4):655-659.
PMID: 35908970
Metaplastic breast cancer (MBC) is characterized by the histological presence of a mixture of epithelial and mesenchymal-like elements. However, MBC responds poorly to chemotherapy. Due to its rarity, there is...
6.
Hirata T, Ozaki S, Tabata M, Iwamoto T, Hinotsu S, Hamada A, et al.
Intern Med
. 2020 Nov;
60(8):1183-1190.
PMID: 33191320
Objective This study examined the pharmacokinetics, safety and anti-tumor activity of docetaxel at a dose of 100 mg/m in Japanese patients with advanced or recurrent breast cancer. Methods Japanese patients...
7.
Shigematsu H, Hirata T, Nishina M, Yasui D, Ozaki S
Support Care Cancer
. 2020 Feb;
28(10):5005-5011.
PMID: 32036471
Purpose: This randomized phase II study was conducted to investigate the efficacy of cryotherapy in preventing peripheral neuropathy and dermatological adverse events in breast cancer patients treated with weekly paclitaxel....
8.
Ota S, Shimonaga T, Yuki S, Kuraoka K, Ogawa T, Hirata T
Anticancer Drugs
. 2019 Nov;
31(3):304-309.
PMID: 31725047
Rhabdomyosarcoma is the most common soft tissue sarcoma that typically occurs in children and adolescents and is rare in adults. Furthermore, as cardiac tumor is rare, adult cardiac rhabdomyosarcoma is...
9.
Shigematsu H, Nishina M, Yasui D, Hirata T, Ozaki S
World J Surg Oncol
. 2019 Feb;
17(1):41.
PMID: 30797231
Background: The prognostic value of sentinel lymph node (SLN) metastases may be minimized by the limited disease burden of lymph node metastases and tailoring adjuvant therapy based on breast cancer...
10.
Suehiro S, Matsuda M, Hirata T, Taniyama D, Kuraoka K, Takasaki T, et al.
J Cardiol Cases
. 2018 Oct;
15(6):181-183.
PMID: 30279774
The heart is an organ where primary malignant tumors rarely develop. In particular, the incidence of cardiac rhabdomyosarcoma (RMS) is extremely low. It has been reported that the risk of...